West Paces Advisors’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

West Paces Advisors’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,196	Closed	-$81.6K	–	593
2022 Q2	$81.6K	Hold	8,196	–	–	0.03%	181
2022 Q1	$81.1K	Hold	8,196	–	–	0.03%	193
2021 Q4	$80.6K	Hold	8,196	–	–	0.03%	192
2021 Q3	$80.6K	Hold	8,196	–	–	0.03%	177
2021 Q2	$80.3K	Buy	+8,196	New	+$80K	0.03%	165

West Paces Advisors's ISLE Position: Q3 2022 in Review

West Paces Advisors sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 8,196 shares — an estimated $81.6K sold.

West Paces Advisors first reported a position in ISLE in Q2 2021 and held it in 5 quarters. The position peaked at $81.6K in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

West Paces Advisors reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
West Paces Advisors sold 8,196 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $81.6K.
West Paces Advisors first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q2 2021 and held it in 5 quarters.
West Paces Advisors's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $81.6K in Q2 2022.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on West Paces Advisors's 13F filing for Q3 2022, filed 19 Dec 2023.